Suerie Moon, Graduate Institute – Institut de hautes études internationales et du développement (IHEID)
The world rightly expressed shock and dismay at Donald Trump’s suspension of US funding for WHO. To respond, other governments, funders and citizens are urgently needed to fill the gap.
The Trump administration has halted funding to the World Health Organization in the middle of the coronavirus pandemic. But what does it actually do with its budget?
African countries face unique challenges in their efforts to limit the spread of COVID-19, but lessons learned in other regions where the coronavirus has already peaked may be helpful.
Knowing genetic associations in specific populations will make it possible to focus prevention and treatment on those who will benefit most, sparing expense and side effects from those who will not.
Office buildings have been left mostly empty for weeks amid the coronavirus pandemic, leaving standing water in pipes where harmful organisms can grow. What happens when those buildings reopen?
There’s no guarantee a coronavirus vaccine will arrive, so we need research to understand the best ways to use facemasks, hand hygiene, and other interventions to control the spread of the disease
We must figure out how to scale the lockdown up and down as needed – possibly several times. We might need to locally switch areas on and off – not the whole country – to deal with isolated outbreaks.
As Africa battles to contain the spread of Coronavirus and limit its impact on the economy, it is imperative that such efforts are driven by local realities.
When restricting the movement of their citizens to slow down the spread of the COVID-19 pandemic, low income countries should tailor measures to local socio-economic circumstances.
It is not surprising that being unhealthy makes you more vulnerable to COVID-19 infection. But what may worry you is just how many Americans are in this high-risk group.
Attempting to defeat these folk theories with science achieved little; the myth busters of the AIDS epidemic were talking past those they were trying to convince.
With recent calls for their use in combating COVID-19, there are concerns that chloroquine and hydroxychloroquine might become unavailable to people who need them.
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
Principal Medical Scientist and Head of Laboratory for Antimalarial Resistance Monitoring and Malaria Operational Research, National Institute for Communicable Diseases
Professor and Programme Director, SA MRC Centre for Health Economics and Decision Science - PRICELESS SA (Priority Cost Effective Lessons in Systems Strengthening South Africa), University of the Witwatersrand